Literature DB >> 28557352

Effect of N-acetylcysteine on motivation, seeking and relapse to ethanol self-administration.

Sophie Lebourgeois1, María Carmen González-Marín1, Jerome Jeanblanc1, Mickael Naassila1, Catherine Vilpoux1.   

Abstract

Alcohol use disorder is a chronic and highly relapsing disorder, characterized by a loss of control over alcohol consumption and craving. Several studies suggest a key role of glutamate in this disorder. In recent years, the modulation of cystine/glutamate exchange via the xc- system has emerged as a new therapeutic alternative for reducing the excitatory glutamatergic transmission observed after ethanol self-administration in both rats and humans. The objective of this study was to determine whether a treatment with N-acetylcysteine (NAC), a cystine prodrug, could reduce ethanol self-administration, ethanol-seeking behavior and reacquisition of ethanol self-administration. Male Long Evans rats were trained to self-administer 20 percent ethanol in operant cages for several weeks. Once the consumption surpassed 1 g of ethanol/kg body weight/15 minutes, the effect of an acute intraperitoneal injection of NAC (0, 25, 50 or 100 mg/kg) 1 hour before the beginning of each test was evaluated on different aspects of the operant self-administration behavior. We demonstrated antimotivational properties of NAC (100 mg/kg), as ethanol-reinforced responding was reduced in a fixed ratio (-35 percent) and in a progressive ratio schedule (-81 percent). NAC also reduced ethanol-seeking behavior (-77 percent) evaluated as extinction responding in a single extinction session. NAC was able to reduce reacquisition in rats that were abstinent for 17 days, while NAC had no effect on ethanol relapse in rats previously exposed to six extinction sessions. Overall, our results demonstrate that NAC limits motivation, seeking behavior and reacquisition in rats, making it a potential new treatment for the maintenance of abstinence.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  N-acetylcysteine; ethanol self-administration; rat; relapse; seeking

Mesh:

Substances:

Year:  2017        PMID: 28557352     DOI: 10.1111/adb.12521

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  15 in total

1.  Pharmacological Treatment of Youth Substance Use Disorders.

Authors:  Lindsay M Squeglia; Matthew C Fadus; Erin A McClure; Rachel L Tomko; Kevin M Gray
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-04-22       Impact factor: 2.576

2.  Effects of Methamphetamine Self-Administration and Extinction on Astrocyte Structure and Function in the Nucleus Accumbens Core.

Authors:  B M Siemsen; C M Reichel; K C Leong; C Garcia-Keller; C D Gipson; S Spencer; J A McFaddin; K N Hooker; P W Kalivas; M D Scofield
Journal:  Neuroscience       Date:  2019-03-26       Impact factor: 3.590

Review 3.  Extrasynaptic therapeutic targets in substance use and stress disorders.

Authors:  Ritchy Hodebourg; Peter W Kalivas; Anna Kruyer
Journal:  Trends Pharmacol Sci       Date:  2021-11-06       Impact factor: 14.819

Review 4.  Sex differences in the glutamate system: Implications for addiction.

Authors:  L L Giacometti; J M Barker
Journal:  Neurosci Biobehav Rev       Date:  2020-03-12       Impact factor: 8.989

5.  N-acetylcysteine: A potential treatment for substance use disorders.

Authors:  Rachel L Tomko; Jennifer L Jones; Amanda K Gilmore; Kathleen T Brady; Sudie E Back; Kevin M Gray
Journal:  Curr Psychiatr       Date:  2018-06

6.  The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.

Authors:  Lindsay M Squeglia; Rachel L Tomko; Nathaniel L Baker; Erin A McClure; George A Book; Kevin M Gray
Journal:  Drug Alcohol Depend       Date:  2018-02-01       Impact factor: 4.492

Review 7.  Neuroimmune signaling in alcohol use disorder.

Authors:  Emma K Erickson; Emily K Grantham; Anna S Warden; R A Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-12-24       Impact factor: 3.533

Review 8.  Pharmacotherapy for Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder: Targeting the Opioidergic, Noradrenergic, Serotonergic, and GABAergic/Glutamatergic Systems.

Authors:  Terril L Verplaetse; Sherry A McKee; Ismene L Petrakis
Journal:  Alcohol Res       Date:  2018

Review 9.  Immune treatments for alcohol use disorder: A translational framework.

Authors:  Lindsay R Meredith; Elizabeth M Burnette; Erica N Grodin; Michael R Irwin; Lara A Ray
Journal:  Brain Behav Immun       Date:  2021-07-31       Impact factor: 19.227

10.  Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol.

Authors:  William W Stoops; Justin C Strickland; Lon R Hays; Abner O Rayapati; Joshua A Lile; Craig R Rush
Journal:  Pharmacol Biochem Behav       Date:  2020-09-04       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.